RUNX1 and acute myeloid leukemia: WS6 markedly decreased MYC and EVI1 in EVI1High primary blasts and EVI1High AML cell lines (Fig. 7D and Supplementary Fig. 11D) and consequently their occupancy at the PA2G4 promoter (Supplementary Fig. 9J).